Pfizer Raises Quarterly Dividend by 7.1%
Pfizer Inc. said its board has raised the pharmaceutical company's quarterly dividend by 7.1%.
KryoLife CEO Defends Cryotherapy After Death at Spa
Safety of cryotherapy questioned.
CVS, Express Scripts Drop Valeant's Philidor; Stock Dives
Shares of Valeant Pharmaceuticals Inc. fell further on Thursday after CVS Health Corp and Express Scripts dropped Philidor Rx from their networks.
How the Apple Watch Can Monitor Your Baby’s Heart Rate
Expecting moms will soon be able to listen to their baby’s heart rate with using their Apple Watch.
Clinton Plan to Cut Health Costs Includes Tax Credits, More Sick Visits
Democratic presidential candidate Hillary Clinton unveiled a plan on Wednesday to lower out-of-pocket health costs, including expanded coverage of sick visits to the doctor and tax credits for those with substantial medical bills.
U.S. Drugmaker Turing to Roll Back 5,000% Price Hike
Turing Pharmaceuticals, a small company that generated outrage over raising the cost of an old anti-infective drug by more than 5,000%, said on Tuesday it would roll back that increase to make sure it remains affordable.
Clinton Proposes $250 Monthly Cap on Prescription Drug Costs
Democratic presidential candidate Hillary Clinton proposed on Tuesday a $250 monthly cap on out-of-pocket prescription drug costs and other measures to stop what she called "price gouging" by pharmaceutical companies.
The New Female Libido Drug: Hot or Hype?
Since its approval of Viagra, the FDA has been under pressure to find a treatment for female sexual dysfunction.
Express Scripts CEO George Paz to retire in May
Pharmacy benefit manager Express Scripts Holding Co said Chief Executive George Paz will retire in May and President Tim Wentworth will succeed him.
Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs
Novartis AG will share the risks and rewards as Amgen Inc. will help develop its pipeline of experimental Alzheimer's disease drugs, in a move that is becoming increasingly commonplace among drug makers eager to address the difficult-to-treat condition.
FDA Approves Amgen's Cholesterol-Lowering Drug Repatha
The U.S. Food and Drug Administration on Thursday approved Amgen Inc's Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease.
What Leaders Can Learn from America’s #1 Cancer Center
A personal story of how an organization's spirt and culture is saving lives.
Can the Health Care Sector Continue on its Incredible Run?
The Healthcare Sector is pumping up tremendous gains and is on a historic run.
Juno Shares Surge on Collaboration Pact With Celgene
Celgene Corp. will make an initial payment of about $1 billion, including a stock purchase, as part of a 10-year collaboration with fellow biotech company Juno Therapeutics Inc. on cancer and autoimmune disease treatments.
Medical Marijuana: Evolution Revolution?
Scientists are mapping the Cannabis genome to increase understanding of the versatile plant’s many mutations, a marijuana version of the hugely influential Human Genome Project.
The End of AIDS—Are We Any Closer?
NIH’S top doctor talks candidly about his fight for an AIDS-Free Generation and the ‘breathtaking’ advances we’ve made in treatments.
A Wonder Drug for Opioid Overdose
U.S. Deaths are spiking from overdose related to heroin, Vicodin and OxyContin. But there is hope, as a drug called naloxone (aka Narcan) has been effective in keeping people alive following an OD.
A Game Changer in Cancer Treatment
Heron Therapeutics stock soars 60% as the company nears cure for chemo related nausea.
Biotech’s Wonder Drug for Overdose Victims
Naloxone is considered a wonder drug to treat heroin or prescription pain medication overdose victims.
How Huge Pharma and PBMs Affect Your Health Care
Decisions that impact the medicine you get.















